Author Archives: Jennifer Walker-Journey

Antipsychotic drugs linked to kidney injury in elderly patients

Posted: August 31, 2014 Pharmaceutical

Antipsychotic medications, including risperidone, can cause kidney injury, especially in elderly patients, according to a new study published in the Annals of Internal Medicine.

New testosterone treatment in development carries fewer side effects

Posted: August 31, 2014 Pharmaceutical

Testosterone levels in men typically drop as a man ages, but when it drops too low it signals a possible problem. In many cases the drop can be associated with obesity, diabetes and circulatory disease.

Combining old diabetes drug with new improves blood sugar control

Posted: August 31, 2014 Pharmaceutical

Combining the commonly used metformin with another class of medication can greatly improve blood sugar control in Type 2 diabetics, according to new research.

Young, African-American dialysis patients at greater risk of dying

Posted: August 30, 2014 Pharmaceutical

Young African-Americans on dialysis are 1.5 times more likely to die than white dialysis patients, according to a study published in the Journal of the American Society of Nephrology.

Hundreds of Risperdal gynecomastia lawsuits filed in Philadelphia court

Posted: August 29, 2014 Pharmaceutical

About 700 product liability lawsuits involving the antipsychotic Risperdal have been filed in Philadelphia Court of Common Pleas alleging use of the drug caused boys and young men to develop breasts, a condition referred to as gynecomastia. Many of the

Drug company testing type 2 diabetes drug designed to have fewer side effects

Posted: August 29, 2014 Pharmaceutical

Drug developer BioKier currently testing a new oral formulation of type 2 diabetes treatment that may prove safer than injectable versions of the drug currently on the market.

Regeneron, Sanofi pay $67.5 million to expedite approval of experimental cholesterol drug

Posted: August 29, 2014 Pharmaceutical

Regeneron Pharmaceuticals and Sanofi are paying $67.5 million to improve the chances of getting their experimental cholesterol-lowering drug on the market before any other drug company with similar cholesterol treatments in development. Regeneron and Sanofi are purchasing a first-of-its-kind voucher

Cancer drug Avastin with chemo granted priority review for treatment of ovarian cancer

Posted: August 28, 2014 Personal Injury

The Food and Drug Administration (FDA) has granted Priority Review status for the cancer drug Avastin (bevacizumab) plus chemotherapy for the treatment of women with recurrent platinum-resistant ovarian cancer. Avastin is already approved to treat specific types of colorectal, lung,

Novel new diabetes treatment fares well in clinical trials

Posted: August 27, 2014 Pharmaceutical

Clinical trials on a novel new type 2 diabetes treatment lowered glucose, did not increase lipids, and was well tolerated in patients with the chronic disease.

Lipitor side effects lawsuits mount against Pfizer

Posted: August 27, 2014 Pharmaceutical

Lawsuits are mounting against Pfizer Inc., alleging the company withheld information that its cholesterol-lowering statin drug Lipitor could cause women to develop type 2 diabetes. In the past five months, Lipitor side effects lawsuits have jumped from 56 to more than